.png)
All authorized agents for medicine are hereby informed that NMRA would not register/renew registration in future without test report for "Nitrosamine impurities" for both "Angiotensin receptor blockers" and "Metformin" with effect from 17.05.2022
(Date: 17 May 2022)
National Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka